These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 6888328

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Phase II evaluation of dianhydrogalactitol in advanced head and neck carcinomas.
    Edmonson JH, Frytak S, Letendre L, Kvols LK, Eagan RT.
    Cancer Treat Rep; 1979; 63(11-12):2081-3. PubMed ID: 526941
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Phase II evaluation of dianhydrogalactitol in lung cancer: a Southwest Oncology Group Study.
    Haas CD, Baker L, Thigpen T.
    Cancer Treat Rep; 1981; 65(1-2):115-7. PubMed ID: 6261943
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Phase II trial of dianhydrogalactitol in metastatic malignant melanoma: a Southwest Oncology Group study.
    Thigpen JT, Al-Sarraf M, Hewlett JS.
    Cancer Treat Rep; 1979 Apr; 63(4):525-8. PubMed ID: 445506
    [Abstract] [Full Text] [Related]

  • 7. Phase II clinical trial of dianhydrogalactitol for remission induction in children with acute leukemia: a Southwest Oncology Group Study.
    Vats TS, Lui V, Trueworthy R, van Eys J.
    Cancer Treat Rep; 1981 Apr; 65(1-2):121-2. PubMed ID: 6939482
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Phase II trial of galactitol 1,2:5,6-dianhydro (NSC 132313) in the treatment of advanced gynecologic malignancies: a Gynecologic Oncology Group study.
    Stehman FB, Blom J, Blessing JA, Ehrlich CE, Mangan C.
    Gynecol Oncol; 1983 Jun; 15(3):381-90. PubMed ID: 6862293
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Dianhydrogalactitol (NSC-132313): phase II study in solid tumors.
    de Jager R, Brugarolas A, Hansen H, Cavalli F, Ryssel H, Siegenthaler P, Clarysse A, Renard J, Kenis Y, Alberto P.
    Eur J Cancer (1965); 1979 Jul; 15(7):971-4. PubMed ID: 385328
    [No Abstract] [Full Text] [Related]

  • 12. Phase II trial of dianhydrogalactitol in the treatment of children with refractory childhood malignancies: a report from the Children's Cancer Study Group.
    Finklestein JZ, Shore N, Krivit W, Hammond D, Higgins G.
    Cancer Treat Rep; 1985 Nov; 69(11):1331-3. PubMed ID: 4092198
    [No Abstract] [Full Text] [Related]

  • 13. Dianhydrogalactitol and cisplatin in combination for advanced cancer of the uterine cervix.
    Vogl SE, Seltzer V, Camacho F, Calanog A.
    Cancer Treat Rep; 1982 Oct; 66(10):1809-12. PubMed ID: 6889913
    [Abstract] [Full Text] [Related]

  • 14. Phase II evaluation of dianhydrogalactitol in the treatment of advanced endometrial adenocarcinoma: a Gynecologic Oncology Group Study.
    Stehman FB, Blessing JA, Delgado G, Louka M.
    Cancer Treat Rep; 1983 Oct; 67(7-8):737-8. PubMed ID: 6871892
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Dianhydrogalactitol and radiation therapy. Treatment of supratentorial glioma.
    Eagan RT, Childs DS, Layton DD, Laws ER, Bisel HF, Holbrook MA, Fleming TR.
    JAMA; 1979 May 11; 241(19):2046-50. PubMed ID: 219269
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.